ABSIAbsci Corporation

ABSI Stock Price, Valuation & Chart | Absci Corporation

Compare

$8.800-0.04 (-0.45%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology ABSI intrinsic value ABSI calculated fair value vs price

Overview Financials Dividends Ratios

ABSI Historical price chart

ABSI Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization1.49B

PE Ratio-11.0

EPS-0.8

Trading Volume2.94M

Today's High/Low9.23/8.36

Dividend Yield0.00

52 Week High/Low12.05/2.24

Shares Outstanding169.40M

ABSI Financial Statement

ABSI Analyst ratings

ABSI Analysis & performance metrics

ABSI Company profile

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in…

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and…

ABSI Management team

Name

Position

Wen Sha

Chief of Staff

Andreas Busch Ph.D.

Chief Innovation Officer & Member of Scientific Advisory Board

Todd Bedrick CPA

Senior Vice President & Chief Accounting Officer

Sean McClainCEO

Founder, Chief Executive Officer, President & Director

Alexander Khan CPA

Vice President of Finance & Head of Investor Relations

Shelby Walker J.D.

Chief Legal Officer

Zachariah Jonasson Ph.D.CFO

Chief Business Officer & Chief Financial Officer

Christine Lemke D.V.M., M.B.A., Ph.D.

Senior Vice President of Portfolio & Growth Strategy

Name

Position

Wen Sha

Chief of Staff

Andreas Busch Ph.D.

Chief Innovation Officer & Member of Scientific Advisory Board

Todd Bedrick CPA

Senior Vice President & Chief Accounting Officer

Sean McClainCEO

Founder, Chief Executive Officer, President & Director

Alexander Khan CPA

Vice President of Finance & Head of Investor Relations

Shelby Walker J.D.

Chief Legal Officer

Zachariah Jonasson Ph.D.CFO

Chief Business Officer & Chief Financial Officer

Christine Lemke D.V.M., M.B.A., Ph.D.

Senior Vice President of Portfolio & Growth Strategy

Management Team

Wen Sha

Chief of Staff

Andreas Busch Ph.D.

Chief Innovation Officer & Member of Scientific Advisory Board

Todd Bedrick CPA

Senior Vice President & Chief Accounting Officer

Sean McClainCEO

Founder, Chief Executive Officer, President & Director

Alexander Khan CPA

Vice President of Finance & Head of Investor Relations

Shelby Walker J.D.

Chief Legal Officer

Zachariah Jonasson Ph.D.CFO

Chief Business Officer & Chief Financial Officer

Christine Lemke D.V.M., M.B.A., Ph.D.

Senior Vice President of Portfolio & Growth Strategy

Management

Wen Sha

Chief of Staff

Andreas Busch Ph.D.

Chief Innovation Officer & Member of Scientific Advisory Board

Todd Bedrick CPA

Senior Vice President & Chief Accounting Officer

Sean McClainCEO

Founder, Chief Executive Officer, President & Director

Alexander Khan CPA

Vice President of Finance & Head of Investor Relations

Shelby Walker J.D.

Chief Legal Officer

Zachariah Jonasson Ph.D.CFO

Chief Business Officer & Chief Financial Officer

Christine Lemke D.V.M., M.B.A., Ph.D.

Senior Vice President of Portfolio & Growth Strategy

Total 8 executives

ABSI Frequently asked questions

What is Absci Corporation (ABSI) Stock Price?

Current stock price of Absci Corporation (ABSI) stock is $8.800. The stock price is -0.45% lower in the session. The intraday range can be seen from this page. Volume of Absci Corporation (ABSI) stock is 2.94M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Absci Corporation (ABSI) stock price going up or down today?

The stock price of Absci Corporation (ABSI) can change with earnings, company news, and overall market sentiment. Absci Corporation operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Absci Corporation stock expensive at its current price?

Whether Absci Corporation looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ABSI on this page is -11.00. EPS on this page is -0.80. Compare those figures with peers and growth expectations before deciding if the current Absci Corporation price is justified.

How has the stock price of Absci Corporation (ABSI) performed historically?

Historical performance for Absci Corporation (ABSI) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ABSI reacted to past earnings and market events.

Should I buy Absci Corporation (ABSI) stock, at this price?

Buying Absci Corporation (ABSI) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.